2-(4--(methylamino)phenyl)-6-hydroxybenzothiazole and Chronic-Disease

2-(4--(methylamino)phenyl)-6-hydroxybenzothiazole has been researched along with Chronic-Disease* in 1 studies

Other Studies

1 other study(ies) available for 2-(4--(methylamino)phenyl)-6-hydroxybenzothiazole and Chronic-Disease

ArticleYear
Risk factors for incident dementia after stroke and transient ischemic attack.
    Alzheimer's & dementia : the journal of the Alzheimer's Association, 2015, Volume: 11, Issue:1

    We hypothesized that chronic brain changes are important substrates for incident dementia after stroke and transient ischemic attack (TIA).. We compared clinical and imaging features between patients with consecutive stroke/TIA with (n = 88) and without (n = 925) incident dementia at 3 to 6 months after a stroke/TIA. Pittsburg compound B (PiB) positron emission tomography was performed in 50 patients, including those with (n = 37) and without (n = 13) incident dementia.. Age, history of diabetes mellitus, severity of white matter changes (WMCs), and medial temporal lobe atrophy (MTLA) were associated with incident dementia. Alzheimer's disease (AD)--like PiB retention was found in 29.7% and 7.7% (P = .032) of patients with and without incident dementia, respectively.. Chronic brain changes including WMCs, MTLA, and AD pathology are associated with incident dementia after stroke/TIA. Interventions targeting these chronic brain changes may reduce burden of vascular cognitive impairment.

    Topics: Age Factors; Aged; Aged, 80 and over; Aniline Compounds; Biomarkers; Brain; Chronic Disease; Cohort Studies; Cross-Sectional Studies; Dementia; Diabetes Mellitus; Female; Humans; Ischemic Attack, Transient; Male; Middle Aged; Neuroimaging; Positron-Emission Tomography; Radiopharmaceuticals; Risk Factors; Severity of Illness Index; Stroke; Temporal Lobe; Thiazoles; White Matter

2015